#targetdiscovery resultados de búsqueda

See the openMe proposal by ⁦@sarahgrosche⁩ and ⁦@anna_koeferle⁩ at Boehringer Ingelheim to find new tumor-specific genetic dependencies #TargetDiscovery #ResearchDiscovery #first4patients opnme.com/opn2experts/cr…


My Novasenta colleague Ram Balasubramanian will be presenting at #bioIT23 conference on May 16. Please send us a message to connect if you want to learn more about our #MachineLearning enabled #targetdiscovery #platform or #immunooncology #pipeline. #knowledgegraph

ManiMohindru's tweet image. My Novasenta colleague Ram Balasubramanian will be presenting at #bioIT23 conference on May 16. Please send us a message to connect if you want to learn more about our #MachineLearning enabled #targetdiscovery #platform or #immunooncology #pipeline. 
#knowledgegraph

We are excited to be partnering w/ Novasenta during #BioIT23. Catch them tomorrow at 3pm EST be presenting their use case - a customized solution (NovaKbaseTM) powered by a #knowledgegraph for target contextualization & prioritization, that accelerates research & #drugdiscovery.



Curious how #genetics is reshaping #drugdiscovery? 🧬 Join our live webinar on 22 Sept to see how Genomics’ insights + platform strengthen #targetdiscovery & validation — from the earliest stages of #research 📅 mailchi.mp/genomics/uherd…


Antibody Therapeutics (IF=4.5, Oxford University Press) 🔥🔥 Mapping the protein–protein interactome in the tumor immune microenvironment academic.oup.com/abt/article/6/… #proteinproteininteraction #targetdiscovery #interactome #tumorimmunemicroenvironment #immunooncology

AntibodyT's tweet image. Antibody Therapeutics (IF=4.5, Oxford University Press)
🔥🔥 Mapping the protein–protein interactome in the tumor immune microenvironment
academic.oup.com/abt/article/6/…
#proteinproteininteraction #targetdiscovery #interactome #tumorimmunemicroenvironment #immunooncology

Check out our snapshot of target discovery for autoimmune diseases 🔎 Access the full report for more insights: hubs.ly/Q02bn0qN0 #TargetDiscovery #Lupus #AI

CausalyAI's tweet image. Check out our snapshot of target discovery for autoimmune diseases 🔎

Access the full report for more insights: hubs.ly/Q02bn0qN0

#TargetDiscovery #Lupus #AI

Drug R&D starts with the target. Validate early to avoid costly pivots and enter antibody discovery with confidence. Explore Target Discovery & Validation: creative-biolabs.com/immuno-oncolog… #TargetDiscovery #TargetValidation #Biotech #CreativeBiolabs

creativebiolabs's tweet image. Drug R&D starts with the target. Validate early to avoid costly pivots and enter antibody discovery with confidence. Explore Target Discovery & Validation: creative-biolabs.com/immuno-oncolog… 
#TargetDiscovery #TargetValidation #Biotech #CreativeBiolabs

See how human-centric AI can rapidly identify and prioritize 8,000+ targets for lung cancer, zeroing in on mediators by which a target affects the disease. Access now: hubs.ly/Q02dyZMW0 #TargetDiscovery #AI


Are you looking to expand your pipeline & accelerate #drugdevelopment? @OGDiscoveryDev connects biopharma leaders with cross-industry stakeholders. Discovery & Development spans the entire early R&D ecosystem - from #targetdiscovery to #drugformulation & #preclinicalresearch.

FDDCongress's tweet image. Are you looking to expand your pipeline & accelerate #drugdevelopment? 
@OGDiscoveryDev connects  biopharma leaders with cross-industry stakeholders. Discovery & Development spans the entire early R&D ecosystem - from #targetdiscovery to #drugformulation & #preclinicalresearch.

🧬 Considering using RNA-seq data for #targetdiscovery or #biomarkerdiscovery? Our 101 tutorials run through the basics of the data processing and analysis steps you'll need to address your scientific questions of interest. Read the guide: pluto.bio/resources/Lear…


.@PhoreMost has achieved a second milestone in its #TargetDiscovery Alliance with @Boehringer. As part of the multi-project collaboration, PhoreMost has deployed its SITESEEKER platform towards novel disease-relevant pathways focusing on retinal health: tinyurl.com/ypvdatat

ZymeComms's tweet image. .@PhoreMost has achieved a second milestone in its #TargetDiscovery Alliance with @Boehringer. As part of the multi-project collaboration, PhoreMost has deployed its SITESEEKER platform towards novel disease-relevant pathways focusing on retinal health: tinyurl.com/ypvdatat

Join us tomorrow for the final webinar in our Multi-Omics ONLINE series where we’ll discuss how #MultiOmics is advancing the field of #targetdiscovery with case studies from GSK and AstraZeneca. Sign up here: hubs.la/Q01xZ8pF0

FLGenomics's tweet image. Join us tomorrow for the final webinar in our Multi-Omics ONLINE series where we’ll discuss how #MultiOmics is advancing the field of #targetdiscovery with case studies from GSK and AstraZeneca. Sign up here: hubs.la/Q01xZ8pF0

If you're attending #byteMAL and happen to cross paths with Mariia or Mirella, feel free to say hello! They're eager to connect, share insights, and maybe even spark some exciting conversations about the future of open science and beyond. 💬✨ #targetdiscovery #cancergenomics

TheHyveNL's tweet image. If you're attending #byteMAL and happen to cross paths with Mariia or Mirella, feel free to say hello! They're eager to connect, share insights, and maybe even spark some exciting conversations about the future of open science and beyond. 💬✨

#targetdiscovery #cancergenomics
TheHyveNL's tweet image. If you're attending #byteMAL and happen to cross paths with Mariia or Mirella, feel free to say hello! They're eager to connect, share insights, and maybe even spark some exciting conversations about the future of open science and beyond. 💬✨

#targetdiscovery #cancergenomics

@BioTechX_ starts tomorrow! Visit Poster #37 on Thursday to learn more about our computational platform, HepNet, from our Head of Discovery Biology, James Longden $ETX #ETX #TargetDiscovery #RNAi #AI

TangramTx's tweet image. @BioTechX_ starts tomorrow! Visit Poster #37 on Thursday to learn more about our computational platform, HepNet, from our Head of Discovery Biology, James Longden $ETX #ETX #TargetDiscovery #RNAi #AI

Join us on Tuesday (31 Jan) at 3pm GMT/10am EDT for the final webinar in our #MultiOmics ONLINE series where we’ll discuss how multi-omics is advancing the field of #targetdiscovery & #drugdiscovery with case studies from @GSK & @AstraZeneca. Sign up here: hubs.la/Q01zsrZL0

FLGenomics's tweet image. Join us on Tuesday (31 Jan) at 3pm GMT/10am EDT for the final webinar in our #MultiOmics ONLINE series where we’ll discuss how multi-omics is advancing the field of #targetdiscovery & #drugdiscovery with case studies from @GSK & @AstraZeneca. Sign up here: hubs.la/Q01zsrZL0

🧬Join us for our upcoming webinar with @QuotientTx and @FlagshipPioneer where we will discuss the transformative role of somatic genomics data for the identification of drug targets and the importance of Open Science! 👉 Register now: hubs.la/Q02RbFd00 #TargetDiscovery

SeqeraLabs's tweet image. 🧬Join us for our upcoming webinar with @QuotientTx and @FlagshipPioneer where we will discuss the transformative role of somatic genomics data for the identification of drug targets and the importance of Open Science!

👉 Register now: hubs.la/Q02RbFd00

#TargetDiscovery

Drug repurposing can save a lot of time and resources, and significantly accelerate the drug development process. Chemical proteomics is at the forefront of drug repurposing. To learn more: chomixbio.com #drugdiscovery #targetdiscovery #biotech #chemoproteomics

BiotechCho14599's tweet image. Drug repurposing can save a lot of time and resources, and significantly accelerate the drug development process.
Chemical proteomics is at the forefront of drug repurposing. To learn more: chomixbio.com

#drugdiscovery #targetdiscovery #biotech #chemoproteomics

Wishing a warm #FOGBoston welcome to Clement Chatelain, Head of Genetics and Genomics @Sanofi, who will be speaking on Sanofi's Genetic Data Lake for supporting #targetdiscovery and disease prioritization. Join us in June: hubs.la/Q02qM_wk0

FLGenomics's tweet image. Wishing a warm #FOGBoston welcome to Clement Chatelain, Head of Genetics and Genomics @Sanofi, who will be speaking on Sanofi's Genetic Data Lake for supporting #targetdiscovery and disease prioritization. Join us in June: hubs.la/Q02qM_wk0

Antibody Therapeutics (IF=4.5, Oxford University Press) 🔥🔥 Mapping the protein–protein interactome in the tumor immune microenvironment academic.oup.com/abt/article/6/… #proteinproteininteraction #targetdiscovery #interactome #tumorimmunemicroenvironment #immunooncology

AntibodyT's tweet image. Antibody Therapeutics (IF=4.5, Oxford University Press)
🔥🔥 Mapping the protein–protein interactome in the tumor immune microenvironment
academic.oup.com/abt/article/6/…
#proteinproteininteraction #targetdiscovery #interactome #tumorimmunemicroenvironment #immunooncology

Drug R&D starts with the target. Validate early to avoid costly pivots and enter antibody discovery with confidence. Explore Target Discovery & Validation: creative-biolabs.com/immuno-oncolog… #TargetDiscovery #TargetValidation #Biotech #CreativeBiolabs

creativebiolabs's tweet image. Drug R&D starts with the target. Validate early to avoid costly pivots and enter antibody discovery with confidence. Explore Target Discovery & Validation: creative-biolabs.com/immuno-oncolog… 
#TargetDiscovery #TargetValidation #Biotech #CreativeBiolabs

The Digital Proteome is a multi-species protein expression atlas designed to support #TargetDiscovery and validation. It enables a richer understanding of target accessibility, off-target liabilities, and pathway coverage. 👉Download the poster: biognosys.com/resources/digi…

biognosys's tweet image. The Digital Proteome is a multi-species protein expression atlas designed to support #TargetDiscovery and validation. It enables a richer understanding of target accessibility, off-target liabilities, and pathway coverage.
 
👉Download the poster: biognosys.com/resources/digi…

🔬 CRISPR library screening in breast cancer uncovers key drivers — e.g. NUMEN for PARPi resistance, and Cop1 in TNBC immune regulation. 👉 Explore more: ubigene.us/application/cr… #CRISPR #BreastCancer #TargetDiscovery #FunctionalGenomics

ubigene's tweet image. 🔬 CRISPR library screening in breast cancer uncovers key drivers — e.g. NUMEN for PARPi resistance, and Cop1 in TNBC immune regulation. 
👉 Explore more: ubigene.us/application/cr…
#CRISPR #BreastCancer #TargetDiscovery #FunctionalGenomics

🔍 #CRISPR vs. Omics for target discovery? See the advantages of CRISPR's functional verification & genome-wide screening. Click for insights: 👉ubigene.us/application/cr… #CRISPR2025 #TargetDiscovery #geneediting #biology #science

ubigene's tweet image. 🔍 #CRISPR vs. Omics for target discovery? See the advantages of CRISPR's functional verification & genome-wide screening. Click for insights: 👉ubigene.us/application/cr…

 #CRISPR2025  #TargetDiscovery #geneediting #biology #science

It finally came out ! Excited to share our mini-review published in The Hematologist with Lucy Perez and @apwiita ! A deep dive into surface target discovery for immunotherapy using cutting-edge technologies. ashpublications.org/thehematologis… #Immunotherapy #Hematology #TargetDiscovery


Looking to expand your pipeline & accelerate drug development? #discoverydevelopment connects #biopharma with cross-industry stakeholders. Our community spans the early R&D ecosystem - from #targetdiscovery to drug formulation & #preclinicalresearch 💡tinyurl.com/yc87bdds

OGDiscoveryDev's tweet image. Looking to expand your pipeline & accelerate drug development?
#discoverydevelopment connects #biopharma with cross-industry stakeholders. Our community spans the early R&D ecosystem - from #targetdiscovery to drug formulation & #preclinicalresearch
💡tinyurl.com/yc87bdds

Are you looking to expand your pipeline & accelerate #drugdevelopment? @OGDiscoveryDev connects biopharma leaders with cross-industry stakeholders. Discovery & Development spans the entire early R&D ecosystem - from #targetdiscovery to #drugformulation & #preclinicalresearch.

FDDCongress's tweet image. Are you looking to expand your pipeline & accelerate #drugdevelopment? 
@OGDiscoveryDev connects  biopharma leaders with cross-industry stakeholders. Discovery & Development spans the entire early R&D ecosystem - from #targetdiscovery to #drugformulation & #preclinicalresearch.

🧬Join us for our upcoming webinar with @QuotientTx and @FlagshipPioneer where we will discuss the transformative role of somatic genomics data for the identification of drug targets and the importance of Open Science! 👉 Register now: hubs.la/Q02RbFd00 #TargetDiscovery

SeqeraLabs's tweet image. 🧬Join us for our upcoming webinar with @QuotientTx and @FlagshipPioneer where we will discuss the transformative role of somatic genomics data for the identification of drug targets and the importance of Open Science!

👉 Register now: hubs.la/Q02RbFd00

#TargetDiscovery

Alzheimer's is a scary & impactful disease. @ARUK_ODDI wanted to speed their assessment of new Alzheimer’s disease targets. Ontotext's #TargetDiscovery offering is helping them do that, from the context of the immune system. hubs.la/Q02F-Cgv0


Alzheimer's is a scary & impactful disease. @ARUK_ODDI wanted to speed their assessment of new Alzheimer’s disease targets. Ontotext's #TargetDiscovery offering is helping them do that, from the context of the immune system. hubs.la/Q02F-Dyw0


🧬 Considering using RNA-seq data for #targetdiscovery or #biomarkerdiscovery? Our 101 tutorials run through the basics of the data processing and analysis steps you'll need to address your scientific questions of interest. Read the guide: pluto.bio/resources/Lear…


.@PhoreMost has achieved a second milestone in its #TargetDiscovery Alliance with @Boehringer. As part of the multi-project collaboration, PhoreMost has deployed its SITESEEKER platform towards novel disease-relevant pathways focusing on retinal health: tinyurl.com/ypvdatat

ZymeComms's tweet image. .@PhoreMost has achieved a second milestone in its #TargetDiscovery Alliance with @Boehringer. As part of the multi-project collaboration, PhoreMost has deployed its SITESEEKER platform towards novel disease-relevant pathways focusing on retinal health: tinyurl.com/ypvdatat

If you didn’t have a chance to join us at #AACR24, our posters are now available online! Download now to explore how advancements in genomics technologies can be used to elucidate mechanisms of #cancer, drive therapeutic #targetdiscovery, & more: web.azenta.com/events/aacr-20…

AzentaSciences's tweet image. If you didn’t have a chance to join us at #AACR24, our posters are now available online! Download now to explore how advancements in genomics technologies can be used to elucidate mechanisms of #cancer, drive therapeutic #targetdiscovery, & more: web.azenta.com/events/aacr-20…
AzentaSciences's tweet image. If you didn’t have a chance to join us at #AACR24, our posters are now available online! Download now to explore how advancements in genomics technologies can be used to elucidate mechanisms of #cancer, drive therapeutic #targetdiscovery, & more: web.azenta.com/events/aacr-20…
AzentaSciences's tweet image. If you didn’t have a chance to join us at #AACR24, our posters are now available online! Download now to explore how advancements in genomics technologies can be used to elucidate mechanisms of #cancer, drive therapeutic #targetdiscovery, & more: web.azenta.com/events/aacr-20…
AzentaSciences's tweet image. If you didn’t have a chance to join us at #AACR24, our posters are now available online! Download now to explore how advancements in genomics technologies can be used to elucidate mechanisms of #cancer, drive therapeutic #targetdiscovery, & more: web.azenta.com/events/aacr-20…

If you're attending #byteMAL and happen to cross paths with Mariia or Mirella, feel free to say hello! They're eager to connect, share insights, and maybe even spark some exciting conversations about the future of open science and beyond. 💬✨ #targetdiscovery #cancergenomics

TheHyveNL's tweet image. If you're attending #byteMAL and happen to cross paths with Mariia or Mirella, feel free to say hello! They're eager to connect, share insights, and maybe even spark some exciting conversations about the future of open science and beyond. 💬✨

#targetdiscovery #cancergenomics
TheHyveNL's tweet image. If you're attending #byteMAL and happen to cross paths with Mariia or Mirella, feel free to say hello! They're eager to connect, share insights, and maybe even spark some exciting conversations about the future of open science and beyond. 💬✨

#targetdiscovery #cancergenomics

Ontotext will be exhibiting again at @bioitworld Expo next week, April 15-17. Drop by booth 420 to learn how our AI-Powered #TargetDiscovery solution accelerates medical research & #drugdiscovery hubs.la/Q02sfDdc0

ontotext's tweet image. Ontotext will be exhibiting again at @bioitworld Expo next week, April 15-17. 

Drop by booth 420 to learn how our AI-Powered #TargetDiscovery solution accelerates medical research & #drugdiscovery hubs.la/Q02sfDdc0

Are you interested in advancing your drug discovery and development projects? Then download our eBook 𝘀𝗶𝗻𝗴𝗹𝗲-𝗰𝗲𝗹𝗹 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗶𝗻 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁: hubs.ly/Q02rDncf0 #singlecellsequencing #drugdevelopment #targetdiscovery


No hay resultados para "#targetdiscovery"

We are delighted to announce our new partnership in artificial intelligence and machine learning for target discovery with @lifearc1. bit.ly/2DDMEoW #ArtificialIntelligence #MachineLearning #targetdiscovery #therapy #disease #treatment #therapeutic

TheMilnerInst's tweet image. We are delighted to announce our new partnership in artificial intelligence and machine learning for target discovery with @lifearc1. 

bit.ly/2DDMEoW

#ArtificialIntelligence #MachineLearning #targetdiscovery #therapy #disease #treatment #therapeutic

siPOOL Summer Sale - 20% siPOOLs are known for reliable RNAi gene knockdown. Use siPOOLs for #targetvalidation and #targetdiscovery or study molecular mechanisms, i.e. #SARSCoV2 #mechanismofinfection Order here: buff.ly/2T0OBA0

siTOOLsBiotech's tweet image. siPOOL Summer Sale - 20%
siPOOLs are known for reliable RNAi gene knockdown. 
Use siPOOLs for #targetvalidation and #targetdiscovery or study molecular mechanisms, i.e. #SARSCoV2 #mechanismofinfection 
Order here: buff.ly/2T0OBA0

Drug R&D starts with the target. Validate early to avoid costly pivots and enter antibody discovery with confidence. Explore Target Discovery & Validation: creative-biolabs.com/immuno-oncolog… #TargetDiscovery #TargetValidation #Biotech #CreativeBiolabs

creativebiolabs's tweet image. Drug R&D starts with the target. Validate early to avoid costly pivots and enter antibody discovery with confidence. Explore Target Discovery & Validation: creative-biolabs.com/immuno-oncolog… 
#TargetDiscovery #TargetValidation #Biotech #CreativeBiolabs

Dive into Causaly's Target Discovery Article Pack! Featuring: 🔹Comprehensive articles 🔹Direct insights from our unique platform 🔹Groundbreaking target discovery knowledge ... and numerous other insights! Download Now: hubs.la/Q01_hj1r0 #TargetDiscovery #DrugDiscovery

CausalyAI's tweet image. Dive into Causaly's Target Discovery Article Pack!
Featuring:
🔹Comprehensive articles
🔹Direct insights from our unique platform
🔹Groundbreaking target discovery knowledge
... and numerous other insights!

Download Now: hubs.la/Q01_hj1r0

#TargetDiscovery #DrugDiscovery

Check out our snapshot of target discovery for autoimmune diseases 🔎 Access the full report for more insights: hubs.ly/Q02bn0qN0 #TargetDiscovery #Lupus #AI

CausalyAI's tweet image. Check out our snapshot of target discovery for autoimmune diseases 🔎

Access the full report for more insights: hubs.ly/Q02bn0qN0

#TargetDiscovery #Lupus #AI

Join our Live Webinar ‘Functional #Genomics Strategies’ with Davide Gianni, Associate Director at @AstraZeneca bit.ly/2RVfIvh watch it for free! #DrugDiscovery #TargetDiscovery #RNDSeries19

OGConferences's tweet image. Join our Live Webinar ‘Functional #Genomics Strategies’ with Davide Gianni, Associate Director at @AstraZeneca bit.ly/2RVfIvh watch it for free! #DrugDiscovery #TargetDiscovery #RNDSeries19

We're coding the future of Precision Medicine in Oncology #BIOMAKERS #MolecularOncology #TargetDiscovery

KirchukNicolas's tweet image. We're coding the future of Precision Medicine in Oncology 
#BIOMAKERS #MolecularOncology #TargetDiscovery

Are you looking to expand your pipeline & accelerate #drugdevelopment? @OGDiscoveryDev connects biopharma leaders with cross-industry stakeholders. Discovery & Development spans the entire early R&D ecosystem - from #targetdiscovery to #drugformulation & #preclinicalresearch.

FDDCongress's tweet image. Are you looking to expand your pipeline & accelerate #drugdevelopment? 
@OGDiscoveryDev connects  biopharma leaders with cross-industry stakeholders. Discovery & Development spans the entire early R&D ecosystem - from #targetdiscovery to #drugformulation & #preclinicalresearch.

@BioTechX_ starts tomorrow! Visit Poster #37 on Thursday to learn more about our computational platform, HepNet, from our Head of Discovery Biology, James Longden $ETX #ETX #TargetDiscovery #RNAi #AI

TangramTx's tweet image. @BioTechX_ starts tomorrow! Visit Poster #37 on Thursday to learn more about our computational platform, HepNet, from our Head of Discovery Biology, James Longden $ETX #ETX #TargetDiscovery #RNAi #AI

During this year’s Discovery Week: Online, one of our most popular panel discussions was centred around Novel Drug Targeting 👉 hubs.la/H0_4q8r0 #drugdiscovery21 #Targetdiscovery #Animalmodelling #Targetvalidation #DiscoveryBiology #Genomicsdiscovery #DrugDiscovery

OGConferences's tweet image. During this year’s Discovery Week: Online, one of our most popular panel discussions was centred around Novel Drug Targeting 👉  hubs.la/H0_4q8r0
#drugdiscovery21 #Targetdiscovery #Animalmodelling #Targetvalidation #DiscoveryBiology #Genomicsdiscovery #DrugDiscovery

Elated 2 have presented the work of @mane_ntd @ the International Society for Vaccines Congress in Atlanta #ISV2018 on a rational approach 2 #targetdiscovery for #OnchoVaccine. Proud to have received the #LMICAward. @shintouo @EsohKevin @ntang_mayaah @nkemngo @NebangwaD @MkongJ

RobertAdamu's tweet image. Elated 2 have presented the work of @mane_ntd @ the International Society for Vaccines Congress in Atlanta #ISV2018 on a rational approach 2 #targetdiscovery for #OnchoVaccine. Proud to have received the #LMICAward. @shintouo @EsohKevin @ntang_mayaah @nkemngo @NebangwaD @MkongJ
RobertAdamu's tweet image. Elated 2 have presented the work of @mane_ntd @ the International Society for Vaccines Congress in Atlanta #ISV2018 on a rational approach 2 #targetdiscovery for #OnchoVaccine. Proud to have received the #LMICAward. @shintouo @EsohKevin @ntang_mayaah @nkemngo @NebangwaD @MkongJ
RobertAdamu's tweet image. Elated 2 have presented the work of @mane_ntd @ the International Society for Vaccines Congress in Atlanta #ISV2018 on a rational approach 2 #targetdiscovery for #OnchoVaccine. Proud to have received the #LMICAward. @shintouo @EsohKevin @ntang_mayaah @nkemngo @NebangwaD @MkongJ
RobertAdamu's tweet image. Elated 2 have presented the work of @mane_ntd @ the International Society for Vaccines Congress in Atlanta #ISV2018 on a rational approach 2 #targetdiscovery for #OnchoVaccine. Proud to have received the #LMICAward. @shintouo @EsohKevin @ntang_mayaah @nkemngo @NebangwaD @MkongJ

Are you interested in drug screening and target discovery? Track 3 at this Junes Discovery Europe 2023 delves into On Target, Phenotypic, Affinity and Virtual Based Screening. Find out more here: hubs.la/Q01MRQkd0 #DiscoverySeries23 #DrugScreening #TargetDiscovery

OGConferences's tweet image. Are you interested in drug screening and target discovery? Track 3 at this Junes Discovery Europe 2023 delves into On Target, Phenotypic, Affinity and Virtual Based Screening.

Find out more here: hubs.la/Q01MRQkd0

#DiscoverySeries23 #DrugScreening #TargetDiscovery

My Novasenta colleague Ram Balasubramanian will be presenting at #bioIT23 conference on May 16. Please send us a message to connect if you want to learn more about our #MachineLearning enabled #targetdiscovery #platform or #immunooncology #pipeline. #knowledgegraph

ManiMohindru's tweet image. My Novasenta colleague Ram Balasubramanian will be presenting at #bioIT23 conference on May 16. Please send us a message to connect if you want to learn more about our #MachineLearning enabled #targetdiscovery #platform or #immunooncology #pipeline. 
#knowledgegraph

We are excited to be partnering w/ Novasenta during #BioIT23. Catch them tomorrow at 3pm EST be presenting their use case - a customized solution (NovaKbaseTM) powered by a #knowledgegraph for target contextualization & prioritization, that accelerates research & #drugdiscovery.



Learning about #chordoma disease #biology & #targetdiscovery from @UCL @BroadInstitute @umichmedicine - from tumor dependencies to potential therapeutic targets to role of #brachyury in #chordomaresearch

ChordomaFDN's tweet image. Learning about #chordoma disease #biology & #targetdiscovery from @UCL @BroadInstitute @umichmedicine - from tumor dependencies to potential therapeutic targets to role of #brachyury in #chordomaresearch

Robust #targetvalidation strategies are needed for researchers to proceed confidently in the drug discovery process. Watch Dr. Saharia, VP of Commercial Development at @Synthego, discuss CRISPR’s role in #targetdiscovery, specifically on #cancerdrugtargets bit.ly/3ciSugt

TheScientistLLC's tweet image. Robust #targetvalidation strategies are needed for researchers to proceed confidently in the drug discovery process. Watch Dr. Saharia, VP of Commercial Development at @Synthego, discuss CRISPR’s role in #targetdiscovery, specifically on #cancerdrugtargets bit.ly/3ciSugt

Join Causaly at Booth 107 in Boston from September 25-28 for insights on the role of AI in scientific exploration and advanced target discovery. #DiscoveryOnTarget #BioTech #TargetDiscovery

CausalyAI's tweet image. Join Causaly at Booth 107 in Boston from September 25-28 for insights on the role of AI in scientific exploration and advanced target discovery.

#DiscoveryOnTarget #BioTech #TargetDiscovery

New for 2022, the event features sessions on discovery modalities such as RNA, Novel Targets & AI/ML in #drugdiscovery. It highlights successful strategies in delivering On #TargetDiscovery, #Phenotypic/ #CRISPR Screening, Applications Of #OrganModelling hubs.ly/Q015bVGM0

OGConferences's tweet image. New for 2022, the event features sessions on discovery modalities such as RNA, Novel Targets & AI/ML in #drugdiscovery. It highlights successful strategies in delivering On #TargetDiscovery, #Phenotypic/ #CRISPR Screening, Applications Of #OrganModelling 
hubs.ly/Q015bVGM0

We are committed to advancing evidence-based #targetdiscovery and opening up the field for researchers

biogen's tweet image. We are committed to advancing evidence-based #targetdiscovery and opening up the field for researchers

.@PhoreMost has achieved a second milestone in its #TargetDiscovery Alliance with @Boehringer. As part of the multi-project collaboration, PhoreMost has deployed its SITESEEKER platform towards novel disease-relevant pathways focusing on retinal health: tinyurl.com/ypvdatat

ZymeComms's tweet image. .@PhoreMost has achieved a second milestone in its #TargetDiscovery Alliance with @Boehringer. As part of the multi-project collaboration, PhoreMost has deployed its SITESEEKER platform towards novel disease-relevant pathways focusing on retinal health: tinyurl.com/ypvdatat

Loading...

Something went wrong.


Something went wrong.